iShares Biotechnology ETF Rating $210.53 -0.51 (-0.24%) Closing price 04:00 PM EasternExtended Trading$210.25 -0.28 (-0.13%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOptions ChainOwnershipRatingsSEC FilingsShort Interest iShares Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.69Holdings in IBB have an aggregate rating of Moderate Buy based on 527 analyst ratings issued in the past year covering 25 companies (69.2% of the portfolio).IBB Aggregate Price Target$210.53High Prediction$210.53Average Prediction$210.53Low Prediction$210.53Holdings in IBB have an aggregate price target of $210.53 and a range of $210.53 to $210.53 covering 25 companies (69.2% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBB Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings8.16%GILDGilead Sciences$149.05-1.5%Moderate Buy$158.78 6.5%294.0837 of 5 stars7.65%VRTXVertex Pharmaceuticals$522.81-0.7%Moderate Buy$575.13 10.0%233.5165 of 5 starsAnalyst Forecast7.53%AMGNAmgen$421.51-0.5%Hold$385.25 -8.6%303.3823 of 5 starsAnalyst Forecast5.57%REGNRegeneron Pharmaceuticals$758.27+1.0%Moderate Buy$802.18 5.8%244.0112 of 5 starsTrending NewsAnalyst Upgrade5.02%MRNAModerna$192.57-5.4%Hold$77.83 -59.6%251.9736 of 5 starsTrending NewsAnalyst DowngradeGap Down3.88%NTRANatera$413.31-0.3%Moderate Buy$336.07 -18.7%231.8992 of 5 stars3.77%ARGXargenex$958.91-1.2%Moderate Buy$1,158.61 20.8%244.2088 of 5 stars2.91%ILMNIllumina$273.68+0.6%Hold$209.75 -23.4%181.9315 of 5 starsAnalyst Forecast2.72%RVMDRevolution Medicines$205.26+0.4%Moderate Buy$234.33 14.2%243.0192 of 5 starsAnalyst ForecastAnalyst Revision2.35%ALNYAlnylam Pharmaceuticals$246.74-2.9%Moderate Buy$366.90 48.7%243.6366 of 5 starsAnalyst Forecast2.34%BIIBBiogen$225.88-0.5%Moderate Buy$230.14 1.9%322.5255 of 5 stars2.14%ONCBeOne Medicines$365.94+0.2%Buy$402.71 10.0%173.5465 of 5 starsPositive NewsInsider Trade1.85%INSMInsmed$114.14-1.3%Buy$200.57 75.7%253.602 of 5 starsAnalyst Forecast1.77%INCYIncyte$121.35-1.5%Moderate Buy$124.80 2.8%253.2679 of 5 starsAnalyst Forecast1.38%UTHRUnited Therapeutics$541.89+12.5%Moderate Buy$621.00 14.6%143.7575 of 5 starsInsider TradeHigh Trading Volume1.36%GMABGenmab A/S$35.67+0.3%Moderate Buy$39.50 10.7%134.0321 of 5 starsOptions VolumeHigh Trading Volume1.34%ROIVRoivant Sciences$36.57+0.2%Moderate Buy$45.64 24.8%132.8841 of 5 stars1.00%ASNDAscendis Pharma A/S$227.83-0.1%Buy$310.75 36.4%214.8087 of 5 stars0.99%NBIXNeurocrine Biosciences$141.84+2.5%Moderate Buy$202.73 42.9%244.752 of 5 starsAnalyst Forecast0.98%MEDPMedpace$624.18+0.3%Hold$602.27 -3.5%132.3006 of 5 starsTrending NewsAnalyst ForecastInsider Trade0.98%EXELExelixis$58.41-0.4%Hold$50.29 -13.9%202.9416 of 5 stars0.98%CRLCharles River Laboratories International$295.910.0%Moderate Buy$300.11 1.4%173.1761 of 5 starsAnalyst Forecast0.91%HALOHalozyme Therapeutics$110.40-1.0%Moderate Buy$91.20 -17.4%132.8116 of 5 stars0.83%BMRNBioMarin Pharmaceutical$60.04+0.3%Moderate Buy$89.17 48.5%244.1693 of 5 stars0.83%TWSTTwist Bioscience$193.24+3.8%Moderate Buy$105.73 -45.3%121.2635 of 5 starsAnalyst Forecast This page (NASDAQ:IBB) was last updated on 9/30/2026 by MarketBeat.com Staff. From Our PartnersHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredShould You Convert a Traditional IRA to a Roth After 60?Considering a Roth conversion after 60? The upside includes no income limits on conversions, potential tax-fre...SmartAsset | SponsoredI've seen this movie before (last time: 17,556%)My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called ...Crypto 101 Media | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
